Bacteraemia due to extended-spectrum  -lactamase-producing Escherichia coli (ESBL-EC) in cancer patients: clinical features, risk factors, molecular epidemiology and outcome

Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome

(2009) M. Ortega et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies

(2009) Enrico M. Trecarichi et al.   JOURNAL OF INFECTION

Prospective Study of Fecal Colonization by Extended-Spectrum- -Lactamase-Producing Escherichia coli in Neutropenic Patients with Cancer

(2008) L. Calatayud et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Community Infections Caused by Extended-Spectrum β-Lactamase–Producing Escherichia coli

(2008) Jesús Rodríguez-Baño et al.   ARCHIVES OF INTERNAL MEDICINE

Risk factors for the acquisition of carbapenem-resistant Escherichia coli among hospitalized patients

(2008) Min-Hyok Jeon et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Faecal carriage of extended-spectrum  -lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology

(2008) J. Rodriguez-Bano et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Infections due to Escherichia coli producing extended-spectrum β-lactamase among hospitalised patients: factors influencing mortality

(2008) C. Peña et al.   JOURNAL OF HOSPITAL INFECTION

Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern

(2008) Johann DD Pitout et al.   LANCET INFECTIOUS DISEASES

Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli

(2007) J. Rodríguez-Baño et al.   CLINICAL MICROBIOLOGY AND INFECTION